Transforming Supply Chain Risks Into a Competitive Advantage in the CRO-CDMO Space: The Syngene Story

By Syngene International

The Covid-19 pandemic led to a widespread supply crunch in the life sciences industry and revealed how inadequate existing supply chains are in managing unexpected disruptions of a global scale. The aftermath? Supply chain operations emerging from decades of back-office obscurity to becoming the focal point of board rooms and C-suites today.

In this white paper, we discuss the typical supply chain challenges faced by global CROs and CDMOs. You will also learn how Syngene, a leading CRO-CDMO for small and large molecules, has transformed its supply chain to mitigate these risks and turned them into a competitive advantage.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.